Stevanato Group (NYSE:STVN) Reaches New 52-Week Low – Here’s Why

Shares of Stevanato Group S.p.A. (NYSE:STVN) reached a new 52-week low on Thursday . The stock traded as low as €13.82 and last traded at €13.88, with a volume of 174568 shares trading hands. The stock had previously closed at €14.18.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on STVN. Jefferies Financial Group set a $17.50 price target on shares of Stevanato Group in a research report on Tuesday, February 10th. Morgan Stanley lowered their price objective on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a research report on Friday, March 6th. Wall Street Zen lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Weiss Ratings cut shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 11th. Finally, KeyCorp decreased their target price on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, March 5th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Stevanato Group currently has an average rating of “Moderate Buy”.

Stevanato Group Price Performance

The company has a debt-to-equity ratio of 0.23, a current ratio of 1.76 and a quick ratio of 1.26. The stock has a market capitalization of $4.13 billion, a price-to-earnings ratio of 23.54, a price-to-earnings-growth ratio of 1.28 and a beta of 0.57. The company has a 50-day simple moving average of €16.06 and a two-hundred day simple moving average of €20.94.

Institutional Trading of Stevanato Group

Several hedge funds have recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. boosted its stake in Stevanato Group by 10.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock valued at $78,944,000 after purchasing an additional 368,792 shares during the period. TimesSquare Capital Management LLC increased its stake in shares of Stevanato Group by 7.1% in the fourth quarter. TimesSquare Capital Management LLC now owns 3,500,321 shares of the company’s stock valued at $70,426,000 after purchasing an additional 232,645 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Stevanato Group by 7.1% in the third quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock valued at $61,089,000 after purchasing an additional 156,733 shares during the period. Bamco Inc. NY raised its holdings in shares of Stevanato Group by 1.4% during the fourth quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock valued at $40,275,000 after buying an additional 27,965 shares during the last quarter. Finally, Jennison Associates LLC boosted its position in shares of Stevanato Group by 13.7% during the fourth quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock worth $35,671,000 after buying an additional 213,602 shares during the period.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.